Phone: (707) 546-5553
Email Us
1140 Sonoma Avenue 1-A
Santa Rosa, CA 95405

News

Researchers unravel genetic codes to determine why inherited prostate cancer is so deadly

Prostate cancer researchers have discovered a key piece in the genetic puzzle of why men born with a BRCA2 mutation may develop aggressive localized cancers that resist treatment and become lethal for up to 50 per cent of patients within five years. Canadian and Australian prostate cancer researchers have discovered a key piece in the [...]

January 10th, 2017|

Sonablate HIFU Tissue Change Monitoring

HIFU, which stands for high intensity focused ultrasound is a recently approved new technology for prostate tissue ablation. Many urologists have worked with HIFU for several years to offer their patients a minimally invasive treatment option for prostate cancer, either as a part of a clinical trial or at international treatment centers outside the United [...]

December 20th, 2016|

New study suggests a more accurate system for early detection, treatment of prostate cancer

A new study may lead to a more accurate system for early detection, diagnosis, and treatment of prostate cancer. It’s a promising development given prostate cancer is the second most common cancer among men worldwide, responsible for 308,000 deaths in 2012 and estimated to take 26,120 lives in the U.S. alone in 2016. New research [...]

December 6th, 2016|

One year following FDA approval California HIFU is Giving Prostate Cancer Patients Hope for a Healthy Future

Santa Rosa Urologist Dr. Michael Lazar celebrates California HIFU’s first anniversary with look back at October 2015 when HIFU received approval from Food and Drug Administration for use in the U.S. High-intensity focused ultrasound (HIFU) is a technology that targets cancer cells with precision in a one to four-hour procedure that has little or no [...]

November 22nd, 2016|

Researchers Find that blood samples may help predict prostate cancer spread

Researchers have found a group of circulating tumor cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. This is the first time these cell types have been shown to be a promising [...]

November 15th, 2016|

Researchers discover three novel intrinsic subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented at the 58th Annual Meeting of the American Society for [...]

November 1st, 2016|

Dr. Michael Lazar of California HIFU was recently selected as top urology specialist by Sonoma Magazine’s Top Doctors survey

Dr. Michael Lazar, a Santa Rosa urologist and prostate cancer expert, is the only Northern California physician recognized as a leader in the use of high-intensity focused ultrasound (HIFU) for prostate cancer. Sonoma Magazine’s Top Doctor survey was submitted to Sonoma County doctors who were then asked which medical specialist they would most often recommend [...]

October 18th, 2016|

California HIFU Patients Tell Their Stories

California HIFU Patients Tell Their Stories - NEW VIDEO - Cancer patients who have opted for High Intensity Focused Ultrasound (HIFU), a noninvasive prostate cancer treatment offered by Dr. Michael Lazar of California HIFU, speak out about why they chose HIFU over other options, and what they have experienced as a result. Click on the [...]

October 10th, 2016|

Researchers say genomic fingerprinting important for treating prostate cancer

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans; however, in the majority of cases involving multiple prostate tumors, only the largest tumor is typically fingerprinted -- resulting in more aggressive tumors potentially going undetected. [...]

October 4th, 2016|

New trial results encourage patients to weigh long-term impact of treatment options with their doctors

(Published on ScienceDaily - September 15, 2016) In light of the findings from the Prostate Testing for Cancer and Treatment (ProtecT) trial published in the New England Journal of Medicine, the American Society for Radiation Oncology (ASTRO) would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize [...]

September 20th, 2016|